LUMO - Lumos Pharma GAAP EPS of -$1.09 misses by $0.02 revenue of $0.53M beats by $0.33M
2023-08-09 16:37:39 ET
- Lumos Pharma press release ( NASDAQ: LUMO ): Q2 GAAP EPS of -$1.09 misses by $0.02 .
- Revenue of $0.53M (+32.5% Y/Y) beats by $0.33M .
- Ended the quarter on June 30, 2023 with cash, cash equivalents and short-term investments totaling $50.9 million compared to $67.4 million on December 31, 2022.
For further details see:
Lumos Pharma GAAP EPS of -$1.09 misses by $0.02, revenue of $0.53M beats by $0.33M